management
cystic
fibrosis
observation
gentamycin
used
antibiotic
pulmonary
infection
associated
cystic
fibrosis
hospitalized
symptomatic
patient
cystic
fibrosis
intensive
pulmonary
therapy
severely
ill
patient
admitted
period
study
included
course
intensive
treatment
garamycin
pediatric
injectable
containing
mg
ml
active
ingredient
administered
intravenously
patient
divided
dos
mg
kg
day
purpose
study
evaluate
tolerance
pharmacokinetics
efficacy
garamycin
administered
parenterally
cystic
fibrosis
patient
serious
infection
course
treatment
clinical
improvement
rated
follows
significant
definite
improvement
moderate
improvement
slight
improvement
change
use
garamycin
pediatric
injectable
safe
helpful
management
pulmonary
infectious
complication
cystic
fibrosis
employed
along
well
established
modality
therapy
